Maximizing Medical Affairs’ Role in Respiratory Launches

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Medical Affairs Product Launch in Respiratory: Roles, Collaboration, and Evolution”

STUDY OVERVIEW

The Medical Affairs function plays a pivotal role in respiratory product launches, where their leadership, collaboration, and strategic adaptation is critical to ensure that innovative treatments reach patients swiftly and effectively.

Best Practices, LLC undertook this benchmarking research to investigate the evolving role of Medical Affairs in respiratory product launches, focusing on leadership, cross-functional collaboration, and adaptation to new challenges. The research offers actionable insights into driving successful launches in a field where patient needs and clinical advancements must align.

KEY TOPICS

Medical Leadership Roles and Launch Activity Effectiveness in Respiratory
Ensuring Cross-functional Alignment and Collaboration in Respiratory Product Launches
Adopting to Ongoing Changes in Medical Landscape

KEY METRICS

Medical Affairs’ leadership role in respiratory product launches
Optimizing Medical Affairs launch activities in respiratory
Improvement areas for Medical Affairs around respiratory product launches
Medical Affairs’ internal collaboration for respiratory launch success
Medical Affairs’ cross-functional team role in respiratory product launches

SAMPLE KEY FINDINGS

Medical Leadership Roles: The top quartile of 26 high-value activities includes planning advisory boards, training internally on disease state, developing medical strategy, conducting medical education and ensuring medical communication execution.

METHODOLOGY

This benchmarking study engaged 20 Medical leaders from 16 leading life sciences organizations. The study insights are drawn primarily from Medical Directors and upper management executives, representing nearly 80% of the benchmark class.

Industries Profiled:
Pharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Biopharmaceutical; Consulting; Consumer Products

Companies Profiled:
AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; Cipla; Eurofarma; Genentech; Gr�nenthal; Labaid Group; Matinas BioPharma; MEDiSTRAVA; Novartis; Sandoz; Sunovion; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Medical Affairs Product Launch in Respiratory: Roles, Collaboration, and Evolution

ID: 5831

Features:

Pages/Slides: 31

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C1E8164781977F6800258B9000295565
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-product-launch-in-respiratory-roles-collaboration-evolution?opendocument
18
19opendocument
2018.97.9.168
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB